37 | Reserved 00 | Retired | Retired | Retired | Retired | Retired | Retired |
50 | NAACCR Record Version | | | Added Value 210 | | | Added Code 210 |
89 | County at DX Analysis | | | | | Corrected bullets 3, 4 | |
145 | Census Tr Poverty Indictr | | Updated NPCR; | | Revised | Revised | |
161 | Race 2 | | Updated CoC; | | | | |
162 | Race 3 | | Updated CoC; | | | | Source of Standard |
163 | Race 4 | | Updated CoC; | | | | |
164 | Race 5 | | Updated CoC; | | | | |
170 | Race Coding Sys--Current | | Updated CoC; | | | | |
180 | Race Coding Sys--Original | | Updated CoC; | | | | |
190 | Spanish/Hispanic Origin | | Updated SEER; | | | | |
193 | Race--NAPIIA(derived API) | | Updated SEER; | | | | |
241 | Date of Birth Flag | | Updated CoC; | | | | |
252 | Birthplace--State | | | | Revised | Revised | |
272 | Census Ind Code 2010 CDC | | | | | | Updated Code Notes/links |
282 | Census Occ Code 2010 CDC | | | | | | Updated Code Note/links |
330 | Census Occ/Ind Sys 70-00 | | | | Corrected typo only | | Updated link |
370 | Reserved 01 | Retired | Retired | Retired | Retired | Retired | Retired |
441 | Grade Path Value | | Updated NPCR; | | | | |
449 | Grade Path System | | Updated NPCR; | | | | |
450 | Site Coding Sys--Current | | Updated CoC; | | Revised | | |
460 | Site Coding Sys--Original | | Updated CoC; | | Revised | | |
470 | Morph Coding Sys--Current | | Updated CoC; | Added Value B | | | Added Code B |
480 | Morph Coding Sys--Originl | | Updated CoC; | Added Value B | | | Added Code B |
530 | Reserved 02 | Retired | Retired | Retired | Retired | Retired | Retired |
581 | Date of 1st Contact Flag | | Updated CoC; | | Revised | Revised | |
680 | Reserved 03 | Retired | Retired | Retired | Retired | Retired | Retired |
683 | Date Regional Lymph Node Dissection Flag | | SEER updated; Updated CoC; | | | | |
750 | Reserved 04 | Retired | Retired | Retired | Retired | Retired | Retired |
764 | Summary Stage 2018 | | Updated CoC; | | | | |
833 | Date of Sentinel Lymph Node Biopsy Flag | | Updated CoC; | | Revised | | |
880 | TNM Path T | | NPCR updated 8/24/20; | | | | |
890 | TNM Path N | | NPCR updated 8/24/20; | | | | |
900 | TNM Path M | | NPCR updated 8/24/20; | | | | |
910 | TNM Path Stage Group | | NPCR updated 8/24/20; | | | | |
920 | TNM Path Descriptor | | NPCR updated 8/24/20; | | | | |
940 | TNM Clin T | | NPCR updated 8/24/20; | | | | |
950 | TNM Clin N | | NPCR updated 8/24/20; | | | | |
960 | TNM Clin M | | NPCR updated 8/24/20; | | | | |
970 | TNM Clin Stage Group | | NPCR updated 8/24/20; | | | | |
980 | TNM Clin Descriptor | | NPCR updated 8/24/20; | | | | |
1021 | AJCC TNM Post Therapy Path (yp) T | | | Revised | Revised Description | | |
1022 | AJCC TNM Post Therapy Path (yp) N | | | Revised | Revised Description | | |
1023 | AJCC TNM Post Therapy Path (yp) M | | | Revised | Revised Description | | Revised |
1024 | AJCC TNM Post Therapy Path (yp) Stage Group | | | Revised | Revised Description | | |
1033 | AJCC TNM Post Therapy Path (yp) T Suffix | | | Revised | Revised Description | | |
1035 | AJCC TNM Path N Suffix | | | Fixed typo only | | | Updated Code (f) (10/28/20) |
1036 | AJCC TNM Post Therapy Path (yp) N Suffix | | | Revised | Revised Description | | Updated Code (f) (10/29/2020) |
1060 | TNM Edition Number | | NPCR updated 8/24/20; | Added allowable values. | | | Updated Code 8; Added Code 9 |
1062 | AJCC TNM Post Therapy Clin (yc) T | New | New | New | New | New | New |
1063 | AJCC TNM Post Therapy Clin (yc) T Suffix | New | New | New | New | New | New |
1064 | AJCC TNM Post Therapy Clin (yc) N | New | New | New | New | New | New |
1065 | AJCC TNM Post Therapy Clin (yc) N Suffix | New | New | New | New | New | New |
1066 | AJCC TNM Post Therapy Clin (yc) M | New | New | New | New | New | New |
1067 | AJCC TNM Post Therapy Clin (yc) Stage Group | New | New | New | New | New | New |
1068 | Grade Post Therapy Clin (yc) | New | New | New | New | New | New |
1180 | Reserved 05 | Retired | Retired | Retired | Retired | Retired | Retired |
1190 | Reserved 06 | Retired | Retired | Retired | Retired | Retired | Retired |
1201 | RX Date Surgery Flag | | Updated CoC; | | | Revised | |
1211 | RX Date Radiation Flag | | Updated SEER; Updated CoC; | | | Revised | |
1221 | RX Date Chemo Flag | | Updated CoC; | | | Revised | |
1231 | RX Date Hormone Flag | | Updated CoC; | | | Revised | |
1241 | RX Date BRM Flag | | Updated CoC; | | | Revised | |
1251 | RX Date Other Flag | | Updated SEER; Updated CoC; | | | Revised | |
1270 | Date 1st Crs RX CoC | | | | Revised | Revised | |
1271 | Date 1st Crs RX CoC Flag | | Updated CoC; | | Revised | Revised | |
1281 | RX Date DX/Stg Proc Flag | | Updated CoC; | | Revised | Revised | |
1300 | Reserved 07 | Retired | Retired | Retired | Retired | Retired | Retired |
1330 | RX Summ--Reconstruct 1st | | Updated SEER; | | Revised | Revised | |
1460 | RX Coding System--Current | | Updated CoC; | | | | |
1505 | Phase I Radiation to Draining Lymph Nodes | | | Revised | | | |
1506 | Phase I Radiation Treatment Modality | | | 9/18/20: added Value "98" | | | Corrected Code 14; Added Code 98; revised Code 99; |
1516 | Phase II Radiation Treatment Modality | | | 9/18/20: Added Value "98" | | | 9/18/20: Added Code 98; |
1526 | Phase III Radiation Treatment Modality | | | 9/18/20: Added Value "98" | | | 9/18/20: Added code 98; |
1632 | Neoadjuvant Therapy | New | New | New | New | New | New |
1633 | Neoadjuvant Therapy-Clinical Response | New | New | New | New | New | New |
1634 | Neoadjuvant Therapy-Treatment Effect | New | New | New | New | New | New |
1646 | RX Summ--Surg Site 98-02 | | Updated SEER; | | Revised | Revised | |
1650 | Reserved 08 | Retired | Retired | Retired | Retired | Retired | Retired |
1740 | Reserved 09 | Retired | Retired | Retired | Retired | Retired | Retired |
1751 | Date of Last Contact Flag | | Updated CoC; | | Revised | Revised | |
1773 | Date of Last Cancer (tumor) Status Flag | | Updated CoC; | | | | |
1775 | Record Number Recode | | Updated NPCR; | | | Revised | |
1782 | Surv-Date Active Followup | | Updated NPCR; | | Revised | Revised | |
1783 | Surv-Flag Active Followup | | Updated NPCR; | | Revised | Revised | |
1784 | Surv-Mos Active Followup | | Updated NPCR; | | Revised | Revised | |
1790 | Follow-Up Source | | Updated CoC; | | Revised | Revised | |
1800 | Next Follow-Up Source | | Updated CoC; | | Revised | | |
1810 | Addr Current--City | | Updated CoC; | | Revised | Revised | |
1820 | Addr Current--State | | Updated CoC; | | Revised | Revised | |
1830 | Addr Current--Postal Code | | Updated CoC; | | Revised | Revised | |
1832 | Addr Current--Country | | Updated CoC; | | Revised | Revised | |
1835 | Reserved 10 | Retired | Retired | Retired | Retired | Retired | Retired |
1861 | Recurrence Date--1st Flag | | Updated SEER; Updated CoC; | | Revised | Revised | |
1900 | Reserved 11 | Retired | Retired | Retired | Retired | Retired | Retired |
1980 | ICD-O-2 Conversion Flag | | Updated CoC; | | Revised | | |
1985 | Over-ride Acsn/Class/Seq | | Updated CoC; | | | | |
1986 | Over-ride HospSeq/DxConf | | Updated CoC; | | Revised | Revised | |
1987 | Over-ride CoC-Site/Type | | Updated CoC; | | Revised | Revised | |
1988 | Over-ride HospSeq/Site | | Updated CoC; | | | | |
1989 | Over-ride Site/TNM-StgGrp | | Updated CoC; NPCR updated 8/24/20; | | | | |
1990 | Over-ride Age/Site/Morph | | Updated CoC; | | Revised | Revised | |
1992 | Over-ride TNM Stage | | NPCR updated 8/24/20; | | | | |
1993 | Over-ride TNM Tis | | NPCR updated 8/24/20; | | | | |
2020 | Over-ride Surg/DxConf | | Updated CoC; | | | | |
2030 | Over-ride Site/Type | | Updated CoC; | | Revised | Revised | |
2040 | Over-ride Histology | | Updated CoC; | | | | |
2070 | Over-ride Leuk, Lymphoma | | Updated CoC; | | Revised | Revised | |
2071 | Over-ride Site/Behavior | | Updated CoC; | | | | |
2074 | Over-ride Site/Lat/Morph | | Updated CoC; | | Revised | Revised | |
2080 | Reserved 13 | Retired | Retired | Retired | Retired | Retired | Retired |
2116 | ICD-O-3 Conversion Flag | | Revised | | Revised | | |
2117 | Schema ID Version Current | New | New | New | New | New | New |
2118 | Schema ID Version Original | New | New | New | New | New | New |
2120 | SEER Coding Sys--Current | | Revised | | Revised | Added Note | Added Code I |
2130 | SEER Coding Sys--Original | | Revised | | Revised | Added Note | Added Code I |
2140 | CoC Coding Sys--Current | | Updated CoC; | | Revised | Revised | Updated Code 09 on 10/29/20; |
2150 | CoC Coding Sys--Original | | Updated CoC; | | Revised | Revised | Updated Code 09 on 10/29/20; |
2152 | CoC Accredited Flag | | | | | Revised Rationale | |
2155 | RQRS NCDB Submission Flag | | Updated CoC;
| | Revised | Added Note | |
2156 | AJCC API Version Current | New | New | New | New | New | New |
2157 | AJCC API Version Original | New | New | New | New | New | New |
2158 | AJCC Cancer Surveillance API Version Current | New | New | New | New | New | New |
2159 | AJCC Cancer Surveillance API Version Original | New | New | New | New | New | New |
2180 | SEER Type of Follow-Up | | Updated SEER; | | Revised | | |
2200 | Diagnostic Proc 73-87 | | SEER updated; | | Revised | | |
2210 | Reserved 14 | Retired | Retired | Retired | Retired | Retired | Retired |
2230 | Name--Last | | Updated CoC; | Fixed typo only | | | |
2232 | Name--Birth Surname | New | New | New | New | New | New |
2240 | Name--First | | Updated CoC; | Fixed typo only. | Revised | Revised | |
2250 | Name--Middle | | Updated CoC;
| Fixed typo only. | Revised | | |
2280 | Name--Alias | | Revised | Fixed typo only. | Revised second sentence | Revised | |
2300 | Medical Record Number | Increased Length from 11 to 15 | Updated CoC; | | Changed Source of Standard; Deleted 2nd sentence of Description | Revised | |
2315 | Medicare Beneficiary Identifier | | Updated NPCR; | | | | |
2320 | Social Security Number | | Updated CoC; | | Revised | | |
2330 | Addr at DX--No & Street | | Updated CoC; | | | | |
2335 | Addr at DX--Supplementl | | Updated CoC;
| | | | |
2350 | Addr Current--No & Street | | Updated CoC;
| | Revised | Source of Standard | |
2355 | Addr Current--Supplementl | | Updated CoC;
| | Revised | Revised | |
2360 | Telephone | | Updated CoC; | | Revised | | |
2390 | Name--Maiden | | Updated SEER; Updated NPCR; | Fixed typo only | Revised | Revised | |
2400 | Reserved 15 | Retired | Retired | Retired | Retired | Retired | Retired |
2415 | NPI--Inst Referred From | | Updated CoC; | | Revised | Revised | |
2425 | NPI--Inst Referred To | | Updated CoC; | | Revised | Revised | |
2450 | Reserved 16 | Retired | Retired | Retired | Retired | Retired | Retired |
2465 | NPI--Physician--Managing | | Updated CoC; | | Revised | Revised | |
2475 | NPI--Physician--Follow-Up | | Updated CoC; | | Revised | Revised | |
2510 | Reserved 12 | Retired | Retired | Retired | Retired | Retired | Retired |
2680 | Text--Remarks | | | | Revised | Revised | |
3171 | RX Date Mst Defn Srg Flag | | Updated SEER; Updated CoC; | | | | |
3181 | RX Date Surg Disch Flag | | Updated CoC; | | Revised | Revised | |
3221 | RX Date Rad Ended Flag | | Updated CoC; | | Revised | Revised | |
3231 | RX Date Systemic Flag | | Updated SEER; Updated CoC; | | Revised | Revised | |
3312 | RuralUrban Continuum 2013 | | Revised | Deleted Allowable Value 00, added Blank; Added Format (corrections only) | Revised | Revised | |
3650 | NPCR Derived Clin Stg Grp | | NPCR updated 8/24/20; | | | | |
3655 | NPCR Derived Path Stg Grp | | NPCR updated 8/24/20; | | | | |
3769 | Over-ride CS 20 | | NPCR updated 8/24/20; | | | | |
3804 | Adenopathy | | Updated CCCR | | | Revised | |
3806 | AFP Post-Orchiectomy Range | | | Added Value 5 | | | Added Code 5 |
3809 | AFP Pretreatment Interpretation | | Updated CCCR | | | | |
3811 | Anemia | | Updated CCCR | | | Revised | |
3812 | B symptoms | | Updated CCCR | | | | |
3817 | Breslow Tumor Thickness | | Updated CCCR | | | | |
3818 | CA-125 Pretreatment Interpretation | | Updated CCCR | | | | |
3819 | CEA Pretreatment Interpretation | | Updated CCCR | | | | |
3823 | Circumferential Resection Margin (CRM) | | Updated CCCR | | | | |
3826 | Estrogen Receptor Percent Positive or Range | | | Added Value XX7 | | | Added codes XX7 |
3827 | Estrogen Receptor Summary | | Updated CCCR | | | Revised | Revised Code 0 |
3829 | Esophagus and EGJ Tumor Epicenter | | Updated CCCR | | | Revised | |
3830 | Extranodal Extension Clin (non-Head and Neck) | | | Added Value 4 | | | Revised Code 1; added Coded 4 |
3831 | Extranodal Extension Head and Neck Clinical | | | Added Value 4 | | | Added Code 4 |
3832 | Extranodal Extension Head and Neck Pathological | | Updated CCCR | | | | |
3835 | Fibrosis Score | | | | | | Revised Codes 0,1 |
3836 | FIGO Stage | Changed length | | Changed allowable values and format | | | New Code numbers; added Code for FIGO Stage IB3; deleted code 97 |
3837 | Gestational Trophoblastic Prognostic Scoring Index | | Updated CCCR | | | Revised | |
3838 | Gleason Patterns Clinical | | Updated CCCR; Updated NPCR; | | | | Codes X6, X9 revised |
3839 | Gleason Patterns Pathological | | Updated NPCR; | | | | Codes X6, X9 revised |
3840 | Gleason Score Clinical | | Updated CCCR; Updated NPCR; | | | | |
3841 | Gleason Score Pathological | | Updated CCCR; Updated NPCR; | | | | |
3842 | Gleason Tertiary Pattern | | Updated CCCR; Updated NPCR; NPCR updated 8/24/20; NPCR updated 8/31/20 | | | | |
3844 | Grade Pathological | | Revised | | | | |
3845 | Grade Post Therapy Path (yp) | | Updated NPCR; | Revised | Revised | | Revised Code Note |
3847 | hCG Post-Orchiectomy Range | | | Added Value 5 | | | Added Code 5 |
3850 | HER2 IHC Summary | | Updated CCCR.; updated SEER; Updated CDC; on 23 Nov 2020 updated CCCR; | | | | |
3851 | HER2 ISH Dual Probe Copy Number | | Updated SEER; Updated CDC; | | | | Code XX.9 revised |
3852 | HER2 ISH Dual Probe Ratio | | Updated SEER; Updated CDC; | | | | Code XX.9 revised |
3853 | HER2 ISH Single Probe Copy Number | | Updated SEER; Updated CDC; | Fixed typo only. | | | Code XX.9 revised |
3854 | HER2 ISH Summary | | Updated CCCR; Updated SEER; Updated CDC; on 23 Nov 2020 updated CCCR; | | | | |
3855 | HER2 Overall Summary | | Updated NPCR; Updated CCCR | | | Revised Rationale | |
3856 | Heritable Trait | | Updated CCCR; | | | Revised | |
3857 | High Risk Cytogenetics | | Updated CCCR; | | | Revised | |
3858 | High Risk Histologic Features | | | | Revised | | Revised |
3859 | HIV Status | | Updated CoC; | | | | |
3863 | Ki-67 | | | Added allowable values XXX.4-XXX.6 | Revised Description | Revised Rationale | Added Codes XXX.4-XXX.6 |
3865 | KIT Gene Immunohistochemistry | | Updated CCCR; | | | | |
3866 | KRAS | | | | | | Code 0 revised |
3867 | LDH Post-Orchiectomy Range | | | Added Value 5 | | | Added Code 5 |
3869 | LDH Level | | Updated CCCR; | Revised | Revised | Updated previous names. | |
3883 | LN Size | | Updated CCCR; | | | | |
3885 | Lymphocytosis | | Updated CCCR; | | | Revised | |
3890 | Microsatellite Instability (MSI) | | Updated CCCR; | | | | Revised Codes 0, 2 |
3893 | Mitotic Rate Melanoma | | Updated CCCR; | | | | |
3897 | Number of Cores Examined | | Updated CCCR; | | | | |
3898 | Number of Cores Positive | | Updated CCCR; | | | | |
3899 | Number of Examined Para-Aortic Nodes | | | | | | Code X9 Revised |
3900 | Number of Examined Pelvic Nodes | | | | | | Code X9 revised |
3901 | Number of Positive Para-Aortic Nodes | | | | | | Code X9 revised |
3902 | Number of Positive Pelvic Nodes | | | | | | Code X9 revised |
3904 | Oncotype Dx Recurrence Score-Invasive | | Updated CCCR; | | | | |
3907 | Organomegaly | | Updated CCCR; | | | Revised | Codes 0,1,9 revised |
3908 | Percent Necrosis Post Neoadjuvant | | Updated CCCR; | | | | |
3910 | Peripheral Blood Involvement | | Updated CCCR; | | | Revised | |
3914 | Progesterone Receptor Percent Positive or Range | | | Added Value XX7 | | | Added code XX7 |
3915 | Progesterone Receptor Summary | | Updated CCCR; | | | Revised | Revised Code 0 |
3919 | EOD Prostate Pathologic Extension | | Updated SEER; SEER updated 8/31/20 | Revised | Updated name | Updated names | |
3920 | PSA (Prostatic Specific Antigen) Lab Value | | Updated CCCR; | | | Revised | |
3921 | Residual Tumor Volume Post Cytoreduction | | | Values 10-40, 90-93 deleted; values 50-80 added | | | Codes 10-40, 90-93 deleted; Codes 50-80 added |
3923 | S Category Clinical | | Updated CCCR; | | | Revised | |
3924 | S Category Pathological | | Updated CCCR; | Added Value 5 | | Revised | Added Code 5 |
3926 | Schema Discriminator 1 | | Updated CCCR; | | | | |
3927 | Schema Discriminator 2 | | Updated CCCR; | | | | |
3928 | Schema Discriminator 3 | | Updated CCCR; | | | | |
3930 | Serum Albumin Pretreatment Level | | Updated CCCR; | | | Revised | |
3931 | Serum Beta-2 Microglobulin Pretreatment Level | | Updated CCCR; | | | Revised | |
3932 | LDH Lab Value | | | Revised | Updated Item Name. | Updated previous names. | |
3933 | Thrombocytopenia | | Updated CCCR; | | | Revised | |
3935 | Tumor Growth Pattern | | | | | | Revised Code 9 |
3936 | Ulceration | | Updated CCCR; | | | | |
3937 | Visceral and Parietal Pleural Invasion | | | Deleted Values 1-3; added Value 5 | | | Deleted Codes 1,2,3; Revised Code 4; Added Code 5 |
3938 | ALK Rearrangement | New | New | New | New | New | New |
3939 | EGFR Mutational Analysis | New | New | New | New | New | New |
3940 | BRAF Mutational Analysis | New | New | New | New | New | New |
3941 | NRAS Mutational Analysis | New | New | New | New | New | New |
3942 | CA 19-9 PreTX Lab Value | New | New | New | New | New | New |
3943 | NCDB--SARSCoV2--Test | New | New | New | New | New | New |
3944 | NCDB--SARSCoV2--Pos | New | New | New | New | New | New |
3945 | NCDB--SARSCoV2--Pos Date | New | New | New | New | New | New |
3946 | NCDB--COVID19--Tx Impact | New | New | New | New | New | New |